Open Access

Erratum to: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

  • Hideaki Katagiri1Email author,
  • Shinji Fujikoshi1,
  • Takuya Suzuki2,
  • Kiyoshi Fujita3,
  • Naoya Sugiyama4,
  • Michihiro Takahashi1, 6 and
  • Juan-Carlos Gomez5
BMC Psychiatry201414:313

https://doi.org/10.1186/s12888-014-0313-9

Received: 27 August 2014

Accepted: 27 August 2014

Published: 10 December 2014

The original article was published in BMC Psychiatry 2013 13:20

Abstract

No abstract

Correction

After the publication of this work [1], we became aware that it contains inaccurate description. The correct description on page 5 was “At every timepoint, statistically significant differences were observed between IM olanzapine and IM placebo groups (p < .01) (Figure one)”, and not “At every timepoint, statistically significant differences were observed between IM olanzapine and IM placebo groups (p < .001) (Figure one).” We regret any inconvenience that this inaccuracy might have caused.

Notes

Authors’ Affiliations

(1)
Lilly Research Laboratories Japan
(2)
Ayase Hospital
(3)
Seishinkai Okehazama Hospital Fujita Kokoro Care Center
(4)
Numazu Chuo Hospital
(5)
Lilly Research Laboratories, Lilly Corporate Center
(6)
Takahashi Psychiatric Clinic

References

  1. Katagiri H, Fujikoshi S, Suzuki T, Fujita K, Sugiyama N, Takahashi M, Gomez JC: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation. BMC Psychiatry. 2013, 13: 20-10.1186/1471-244X-13-20.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Katagiri et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement